- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- December 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- April 2024
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- March 2025
- 50 Pages
Global
From €2516EUR$2,650USD£2,122GBP
- Report
- March 2025
- 50 Pages
Global
From €2516EUR$2,650USD£2,122GBP
- Report
- October 2024
- 196 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2024
- 150 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 290 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- May 2024
- 129 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 132 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 130 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- May 2024
- 128 Pages
Global
From €6170EUR$6,499USD£5,204GBP
- Report
- April 2024
- 115 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- January 2025
- 160 Pages
Global
From €7547EUR$7,950USD£6,366GBP
- Report
- October 2024
- 210 Pages
Global
From €7547EUR$7,950USD£6,366GBP
- Report
- June 2024
- 260 Pages
Global
From €7547EUR$7,950USD£6,366GBP
- Report
- April 2024
- 142 Pages
Global
From €7547EUR$7,950USD£6,366GBP

Gabapentin is a medication used to treat certain types of seizures and nerve pain. It is a central nervous system (CNS) drug, meaning it acts on the brain and spinal cord to produce its effects. It is used to treat epilepsy, neuropathic pain, hot flashes, and restless leg syndrome. It is also used off-label to treat anxiety and insomnia. Gabapentin is generally well-tolerated, but can cause side effects such as dizziness, drowsiness, and confusion.
Gabapentin is available in both generic and brand-name forms. It is available in capsule, tablet, and oral solution forms. It is also available as an extended-release tablet, which is taken once daily.
The market for Gabapentin is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the companies in the market include Pfizer, Mylan, Teva Pharmaceuticals, Sun Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more